John Paulson's investment portfolio showcases a strategic inclination towards pharmaceuticals and resource-based companies. Madrigal Pharmaceuticals Inc, a leader in developing innovative therapies for cardiovascular-metabolic diseases, holds a significant position in Paulson's stocks collection, testifying to his faith in biotech's growth potential. Bausch Health Companies Inc further diversifies his interest in the healthcare sector, with this company being a global provider of diversified pharmaceuticals.
The finance sector is represented through BrightSphere Investment Group Inc, where Paulson sees value in asset management firms. This aligns with a broader investment play on financial services industry dynamics.
Heading into natural resources, Perpetua Resources Corp reflects Paulson's bet on sustainable mining operations, indicating an environmentally conscious yet profitability-focused strategy. Novagold Resources Inc complements this approach with its stake in precious metal exploration—particularly gold—which acts as a hedge against market volatility and inflation.
Paulson's top five investments reveal a balanced mix between high-growth potential pharma and steady-eddy resource sectors, signaling a blended risk appetite to seasoned and novice investors alike.
Q1 2022
Increased shares by 181.0%
Added 181.0% in Q1 2022
Q2 2022
Sold -961 Thousand shares
Sold 100% in Q2 2022
Q3 2017
Sold -398 Thousand shares
Sold 100% in Q3 2017
Q3 2017
Sold -145 Thousand shares
Sold 100% in Q3 2017
Q4 2022
Sold -265 Thousand shares
Sold 100% in Q4 2022
Q2 2015
Sold -200 Thousand shares
Sold 100% in Q2 2015
Q2 2016
Sold -280 Thousand shares
Sold 100% in Q2 2016
Q2 2016
Sold -5.33 Million shares
Sold 100% in Q2 2016
Q4 2021
Sold -4.59 Million shares
Sold 100% in Q4 2021
Q2 2017
Sold -471 Thousand shares
Sold 100% in Q2 2017
Q3 2017
Sold -38.6 Thousand shares
Sold 100% in Q3 2017
Q3 2017
Sold -160 Thousand shares
Sold 100% in Q3 2017
Q3 2017
Sold -7.5 Thousand shares
Sold 100% in Q3 2017
Q4 2018
Sold -2.1 Million shares
Sold 100% in Q4 2018
Q4 2018
Sold -778 Thousand shares
Sold 100% in Q4 2018
Q2 2019
Sold -1.38 Million shares
Sold 100% in Q2 2019
Q4 2019
Sold -37 Thousand shares
Sold 100% in Q4 2019
Q2 2023
Sold -1.65 Million shares
Sold 100% in Q2 2023
Q1 2023
Sold -20.3 Thousand shares
Sold 100% in Q1 2023
Q3 2022
Sold -7.5 Million shares
Sold 100% in Q3 2022
Q1 2017
Sold -968 Thousand shares
Sold 100% in Q1 2017
Q1 2017
Sold -968 Thousand shares
Sold 100% in Q1 2017
Q1 2017
Sold -407 Thousand shares
Sold 100% in Q1 2017
Q1 2021
Sold -1.57 Million shares
Sold 100% in Q1 2021
Q1 2021
Sold -6.9 Million shares
Sold 100% in Q1 2021
Q2 2021
Sold -400 Thousand shares
Sold 100% in Q2 2021
Q2 2021
Sold -650 Thousand shares
Sold 100% in Q2 2021
Q3 2021
Sold -3.35 Million shares
Sold 100% in Q3 2021
Q3 2021
Sold -857 Thousand shares
Sold 100% in Q3 2021
Q4 2021
Sold -4.07 Thousand shares
Sold 100% in Q4 2021
Easily embed the chart on your blog or website – it will always update automatically!